Operating Lease, Right-of-Use Asset of INOVIO PHARMACEUTICALS, INC. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
INOVIO PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • INOVIO PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,956,780, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,956,780 -$1,516,068 -18% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $7,356,238 -$1,463,161 -17% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $7,741,757 -$1,414,721 -15% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $8,113,840 -$1,377,895 -15% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $8,472,848 -$624,427 -6.9% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $8,819,399 -$669,339 -7.1% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,156,478 -$709,065 -7.2% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $9,491,735 -$736,472 -7.2% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $9,097,275 -$1,479,802 -14% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $9,488,738 -$1,423,787 -13% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $9,865,543 -$1,385,897 -12% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $10,228,207 -$1,342,819 -12% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $10,577,077 -$1,301,159 -11% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $10,912,525 -$1,260,889 -10% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $11,251,440 -$1,211,566 -9.7% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $11,571,026 -$1,170,270 -9.2% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $11,878,236 -$1,130,335 -8.7% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $12,173,414 -$1,091,730 -8.2% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $12,463,006 -$1,048,375 -7.8% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $12,741,296 -$1,041,713 -7.6% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $13,008,571 -$994,289 -7.1% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $13,265,144 -$957,092 -6.7% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $13,511,381 -$921,098 -6.4% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $13,783,009 -$851,760 -5.8% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $14,002,860 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $14,222,236 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $14,432,479 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $14,634,769 01 Jan 2019 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.